Fig. 2
From: The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment
Bar chart showing the number of patients referred per year between 2014–2020. The number of referrals increased steadily over the years since first referral in 2014. In the year 2020, during coronavirus pandemic, oncology and haematology services temporarily paused new immune checkpoint inhibitor prescription. This impacted in the number of referrals to the cardio-oncology service which dropped from 34 to 16 patients